Navigation Links
Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
Date:2/6/2008

CAMBRIDGE, Mass., Feb. 6 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present a corporate overview at the upcoming BIO CEO & Investor Conference on Tuesday, February 12, 2008 at 9:30 a.m. ET in the Park Avenue Suite Center/North Room at the Waldorf-Astoria Hotel in New York, NY.

The live and archived webcasts of the presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com or directly linking to http://phx.corporate-ir.net/phoenix.zhtml?p=irol- eventDetails&c=131556&eventID=1752370. (Due to the length of URL, please cut and paste into browser). Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis C virus and HIV. For further information about Idenix, please refer to http://www.idenix.com.

Idenix Pharmaceuticals' Contacts:

Media: Teri Dahlman (617) 995-9905

Investors: Amy Sullivan (617) 995-9838


'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
2. Idenix to Host Conference Call Discussing Third Quarter 2007 Financial Results
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
11. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DC....D., has stepped down from his position as a direc...r. Lewis advised the Company that his decision to ...commitments to new leadership positions. , , ...81118/NY46990LOGO ) , , Dr. Harold Koplewic...
(Date:12/4/2008)...e-FirstCall/ -- ExonHit Therapeutics S.A.,(Altern...ny, is pleased to,announce today that it has been...strial Property) during the last edition of its "T... "Since its inception, ExonHit consistently ma...f its intellectual property and in particular from...
(Date:12/3/2008).... 3 GlaxoSmithKline,(LS... a condition relating to a,pending lawsuit in the... of,the outstanding shares of common stock of Gen...1.30 per share in cash without interest and less a...ondition to the completion of the tender offer tha...
(Date:12/3/2008)...FirstCall/ -- Advanced Life Sciences Holdings,In.... Food and Drug,Administration (FDA) has accepted...A) for cethromycin, a novel once-a-day oral antibi...nity acquired pneumonia (CAP). The FDA has,estab...hat the anticipated,target action date of the cet...
Breaking Biology Technology:Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors 2ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI) 2ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI) 3GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 2GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 3Advanced Life Sciences Announces Cethromycin NDA Accepted for Filing by FDA for the Treatment of Community Acquired Pneumonia 2Advanced Life Sciences Announces Cethromycin NDA Accepted for Filing by FDA for the Treatment of Community Acquired Pneumonia 3
...rly known as Automating Peripherals, Inc., announc... API Software, Inc. is a provider of time and att...rces, productivity management, education tracking ...ations. , ,"After 20 years of evolving our produc...ting Peripherals, Inc., we decided we needed to up...
...loper of K-12 software solutions for special educa... announced their online, ASP software that streaml...ams (IEPs) and monitors the progress of children w...oduced in 16 Wisconsin school districts during 200... language therapists, physical therapists, psychol...
...oratories , a producer of active pharmaceutical in...rsenal Capital Partners . ,Arsenal, which targets ...ealthcare companies announced the acquisition, whi...in Waunakee, Wis., is the worlds largest independe...acture anticoagulants used in the prevention and t...
...gether to race the fastest cars they can build and..., scientists and technicians from Ohio State Unive...he goal is to win the $1 million dollar grand priz...nge . , ,The Defense Advanced Research Projects A...d advanced technology achievements that could lead...
Other Biology Technology:Oshkosh Truck Teams with OSU to Compete in DARPA Million Dollar Tech Derby 2Oshkosh Truck Teams with OSU to Compete in DARPA Million Dollar Tech Derby 3
(Date:12/4/2008)...INIA KEY, Fla. -- If you,re looking for bonefish f...about 321,000 to choose from, and that is down sli...due to increased participation among those who are...f Miami,s Rosenstiel School of Marine and Atmosphe...efish census, in conjunction with the conservation...
(Date:12/4/2008)...reat earthquakes and destructive tsunamis over the... of another large earthquake, warns an internation...published in the Dec. 4 issue of the journal Natu..., a magnitude 9.2 in December 2004, produced the m...emory. The cause of that calamity was the rupture...
(Date:12/3/2008)...d H. Jones, deputy executive director of the Inter...ergy Outlook 2008" Dec. 9 at Rice University,s Bak...ress such questions as: Is the world facing a supp...ent? What type of post-Kyoto policy framework migh...levels, and what impact might such a policy framew...
(Date:12/3/2008)...VILLE, Fla. The wild pea pod is big and heavy, wi...f its parent plant. , And yet, like a grounded t...t manages if it has a reasonable chance of escape... the world,s largest experimental landscape devote... or other natural areas have discovered the pea a...
Breaking Biology News(10 mins):Bonefish census reveals population holding steady 2September 2007 Sumatran earthquakes research findings 2September 2007 Sumatran earthquakes research findings 3'World Energy Outlook' to be presented at Rice University Dec. 9 2Rooted plants move mysteriously down greenways, scientists say 2Rooted plants move mysteriously down greenways, scientists say 3Streamline Health Solutions Inc Reports Third Quarter Results 6927 1Streamline Health Solutions Inc Reports Third Quarter Results 6927 2Streamline Health Solutions Inc Reports Third Quarter Results 6927 3Streamline Health Solutions Inc Reports Third Quarter Results 6927 4Streamline Health Solutions Inc Reports Third Quarter Results 6927 5Streamline Health Solutions Inc Reports Third Quarter Results 6927 6Streamline Health Solutions Inc Reports Third Quarter Results 6927 7Streamline Health Solutions Inc Reports Third Quarter Results 6927 8Streamline Health Solutions Inc Reports Third Quarter Results 6927 9Streamline Health Solutions Inc Reports Third Quarter Results 6927 10Streamline Health Solutions Inc Reports Third Quarter Results 6927 11Streamline Health Solutions Inc Reports Third Quarter Results 6927 12Millennium Biotechnologies Inc Launches SURGEX 28TM 29 the First Scientifically Validated Sports Nutritional Product Created from the Medical Market 1952 1Millennium Biotechnologies Inc Launches SURGEX 28TM 29 the First Scientifically Validated Sports Nutritional Product Created from the Medical Market 1952 2Millennium Biotechnologies Inc Launches SURGEX 28TM 29 the First Scientifically Validated Sports Nutritional Product Created from the Medical Market 1952 3Millennium Biotechnologies Inc Launches SURGEX 28TM 29 the First Scientifically Validated Sports Nutritional Product Created from the Medical Market 1952 4Pharmacopeia To Present at BMO Capital Markets Seventh Annual Focus on Healthcare Conference 1950 1Pharmacopeia To Present at BMO Capital Markets Seventh Annual Focus on Healthcare Conference 1950 2Pharmacopeia To Present at BMO Capital Markets Seventh Annual Focus on Healthcare Conference 1950 3Lexicon Pharmaceuticals to Present at the Piper Jaffray 19th Annual Health Care Conference 1948 1Lexicon Pharmaceuticals to Present at the Piper Jaffray 19th Annual Health Care Conference 1948 2
...fect of the sun,s heat on weather balloons largely...tributed to a dispute over the existence of global...ale University and the National Oceanic and Atmosp...ublished in the journal Science, says that direct ...er balloon (radiosonde) probably explains the disc...
... of millions of locusts have, since Biblical times...ague" of major proportions, with the creatures des... now, it was thought that the directions of these ...inds. Now, Hebrew University of Jerusalem scientis...grasshoppers ?namely their polarization vision -- ...
...ersity of Alberta research team has discovered imp... effective treatments for pulmonary arterial hyper...e in the pulmonary arteries caused by uncontrolled...a disease that can lead to heart failure and death...that Survivin, a protein almost exclusively expres...
...chers at Harvard University have found evidence th... visual environment, dynamically adjusting its pro...g the commonplace. The scientists report in this w... that this principle of novelty-detection operates...irst for novelty begins in the eye itself," says M...
Other Biology News:Errors in the measurement of global warming corrected 2Locusts' built-in 'surface analysis' ability directs them to fly overland 2Researchers develop gene therapy to reverse pulmonary arterial hypertension 2Researchers develop gene therapy to reverse pulmonary arterial hypertension 3Retina adapts to seek the unexpected, ignore the commonplace 2
100 adhesive strips.
Homo sapiens palladin
Mouse P-Selectin/CD62P MAb (Clone 127933)
Molecular Biological Resources has extensive abilities cloning and expression of prokaryotic and eukaryotic proteins. Please contact lloconne@molbiores.com to discuss your project. Contact lloconne@
Biology Products: